Journal
MOLECULAR CANCER RESEARCH
Volume 4, Issue 10, Pages 695-707Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-06-0182
Keywords
-
Categories
Funding
- NIGMS NIH HHS [R01-GM067893] Funding Source: Medline
Ask authors/readers for more resources
Recent studies revealed that E3 ubiquitin ligases play important roles in breast carcinogenesis. Clinical research studies have found that (epi)-genetic (deletion, amplification, mutation, and promoter methylation) and expression aberration of Vs are frequent in human breast cancer. Furthermore, many studies have suggested that many E3s are either oncogenes or tumor suppressor genes in breast cancer. In this review, we provide a comprehensive summary of E3s, which have genetic and/or expression aberration in breast cancer. Most cancer-related E3s regulate the cell cycle, p53, transcription, DNA repair, cell signaling, or apoptosis. An understanding of the oncogenic potential of the E3s may facilitate identifying and developing individual E3s as diagnosis markers and drug targets in breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available